ABOUT US

WHAT IS MITO2i?

The Mitochondrial Innovation Initiative (MITO2i) was established as an Institutional Strategic Initiative (ISI) at the University of Toronto in March 2020. The creation of MITO2i was based on the fundamental problem that the role of mitochondria in health and disease is poorly understood, and there is a lack of biomarkers and treatments for mitochondria disease and diseases with underlying mitochondrial dysfunction.

The relationship between mitochondrial dysfunction and severe mitochondrial disease has long been known.  More recent research has established links to a broad range of neurodegenerative and metabolic disorders. This is a game-changer. Unveiling how mitochondrial dysfunction is implicated in multiple diseases will transform medical diagnoses, technologies, and drug delivery systems, leading to a paradigm shift in the prevention, diagnosis, and treatment of disease.   

Dr. Ana Andreazza

Scientific Director of MITO2i and Thomas Zachos Mitochondrial Research Chair, University of Toronto

MITO2i is an interdisciplinary hub that engages all stakeholders in advancing science in the field of mitochondrial medicine & research.

VISION

Become a Global Hub for Mitochondrial Research, Innovation, and Clinical Translation, providing our members and partners with access and opportunities to further the Mitochondrial medicine and improve the quality of life for all.

MISSION

Transform the understanding of mitochondrial health, leading to better diagnoses and treatments that enhance the quality of human life; ultimately transforming healthcare by integrating mitochondrial health into routine care.

KEY INITIATIVES

ADVANCE MITOCHONDRIAL HEALTH THROUGH RESEARCH INNOVATION

Through the facilitation of novel research and the provision of funding opportunities, MITO2i promotes interdisciplinary collaboration to transform and innovate the field of mitochondrial medicine and research.

BUILD AWARENESS IN MITOCHONDRIAL HEALTH, DISEASE & RESEARCH

We offer symposiums, workshops, podcasts, conferences, and more. We hope to promote collaboration, community integration, and opportunity for leaders, patients, advocates, and researchers to come together and exchange knowledge.

INCREASE CAPACITY AMONG MITOCHONDRIAL HEALTH CHAMPIONS

We focus on training the next generation of mitochondrial research leaders by building capacity among trainees and established researchers and clinicians in advancing its interdisciplinary and patient-oriented approach to mitochondrial medicine.

RESEARCH AREAS

MITO2i funds impactful projects that bring novel ways to transform mitochondrial health and have the potential to make direct impact on the quality of life of patients with mitochondrial disease or dysfunction.

MITO2i projects range from mitochondrial disease, neurodegenerative diseases, neuropsychiatric diseases, cancer, autism, and more. These projects have promoted collaboration between disciplines and across institutions, including here at the University of Toronto, affiliated hospitals, and internationally.